BRIEF-Summit's agreement with Sarepta also contains a standstill provision
Oct 4 (Reuters) - Summit Therapeutics Plc :
* Collaboration agreement with Sarepta also contains a standstill provision - SEC filing
* Summit Therapeutics - Believes cash, cash equivalents, certain upfront payments from Sarepta collaboration to be sufficient to fund expenses through 2018 Source text for Eikon: Further company coverage: ;))
© Thomson Reuters 2017 All rights reserved.